课题基金 / 基金详情

Ontogeny of Drug Exposure and Mood Dysregulation.

Ontogeny of Drug Exposure and Mood Dysregulation.
药物暴露和情绪失调的个体发生。
批准号:
8445343
负责人:
Carlos A. Bolanos
金额:
$29.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2015-03-31

项目摘要

项目成果

Carlos A. Bolanos的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):药物使用与抑郁和焦虑(即共同发病)障碍并存是公认的,了解这些神经精神障碍之间的复杂关系具有重要的治疗和预后意义。尽管大多数研究侧重于成人群体,但开始使用药物是在早年,因为有报告表明,青少年(即8-12年级儿童)的终生吸毒率非法物质为37%,香烟为41%。青春期是大脑仍在经历发育变化的关键时期。由于早期生活经历可能导致神经可塑性调节对压力/药物的脆弱性,或精神障碍的易感性,因此重要的是表征早期药物暴露的神经生物学后果,以及它如何影响大脑调节病理行为的途径。这些研究考察了雄性大鼠在青春期接触尼古丁的短期和长期神经生物学后果。这项建议在所提出的发育啮齿动物模型中研究大脑的食欲神经回路在药物暴露的短期和长期行为和生化后果中的作用。这种方法是新颖的,因为它集中在大脑的食欲区域(腹侧被盖区和伏隔核),对动机、奖励和精神运动活动至关重要,而且它集中在药物使用/滥用和情绪压力加剧的发育期。目的1利用旨在评估动物情感状态的行为测试,研究青春期接触尼古丁是否会影响情绪反应。这些评估包括:(A)对情绪诱发刺激(开阔场地、高架+迷宫、强迫游泳应激、蔗糖偏好)的行为反应;(B)自然(蔗糖);(C)药物奖励(尼古丁和可卡因)。目的2利用基础蛋白质生物化学,通过鉴定受尼古丁影响的基因产物,评估这一回路的生化完整性。目的3利用病毒载体确定这些尼古丁调节蛋白的功能意义,以评估它们如何影响青少年的大脑,导致神经适应,这可能会增加成年后神经精神疾病的易感性。从这些研究中获得的数据将提高我们对青春期药物暴露在调节以后生活中的病理行为中所起的作用的理解。
英文摘要
DESCRIPTION (provided by applicant): The co-occurrence of drug use with depression and anxiety (i.e., co-morbidity) disorders is well established, and understanding the complex relationship between these neuropsychiatric disorders is of great therapeutic and prognostic importance. Although most research has focused on adult populations, the initiation into substance use starts during the early years, as reports indicate lifetime drug use rates in adolescents (i.e., children from 8th-12th grades) of 37% for illegal substances and 41% for cigarettes. Adolescence is a critical period during which the brain is still undergoing developmental changes. Because early-life experiences can result in neural plasticity regulating vulnerability to stress/drugs, or predisposition for mental disorders, it is important to characterize the neurobiological consequences of drug exposure during the early years, and how it influences brain pathways to mediate pathological behavior. These studies examine the short- and long-term neurobiological consequences of exposure to nicotine during adolescence in male rats. This proposal studies the role of brain's appetitive neural circuits in the short- and long-term behavioral and biochemical consequences of drug exposure within the proposed developmental rodent model. This approach is novel because it focuses on appetitive regions of the brain (the ventral tegmental area and the nucleus accumbens) important for motivation, reward, and psychomotor activity, and because it focuses on a developmental period where initiation to drug use/abuse and heightened emotional stress often occur. Aim 1 examines whether exposure to nicotine during adolescence influences emotional reactivity using behavioral tests designed to assess an animal's affective state. These include assessing: (a) behavioral reactivity to emotion-eliciting stimuli (open-field, elevated plus-maze, forced swim stress, sucrose preference), (b) natural (sucrose) and (c) drug reward (nicotine and cocaine). Aim 2 assesses the biochemical integrity of this circuit, using basic protein biochemistry, by identifying gene products regulated by exposure to nicotine. Aim 3 determines the functional significance of these nicotine-regulated proteins, using viral vectors, to assess how they influence adolescent brain, resulting in neural adaptations that may increase vulnerability to neuropsychiatric disorders later in adulthood. Data obtained from these studies will improve our understanding of the role drug exposure during adolescence plays in mediating pathological behavior later in life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure
海外基金